8KTier 5
NEOGENOMICS INC 8K
0001628280-26-045350
View on SEC EDGARNeoGenomics appointed Carolyn Starrett to its Board of Directors to bolster its expertise in AI-driven oncology diagnostics.
On June 25, 2026, NeoGenomics, Inc. announced that it has appointed Carolyn Starrett, a seasoned healthcare data and technology executive and former CEO and Board Director of Flatiron Health, to its Board of Directors, adding expertise in AI, real-world data, and oncology insights to support the company’s strategic initiatives and portfolio expansion in cancer diagnostics.
Filing Facts
- CIK
- 1077183
- Ticker
- -
- Form
- 8K
- Source Type
- sec
- Accession
- 0001628280-26-045350
- Alert Tier
- 5